Oseltamivir Phosphate recalls
Oseltamivir Phosphate products have been recalled 2 times, most recently on 28 Feb 2024. The recalling company is usually Lupin Pharmaceuticals. The most common reason is potency & assay.
Total recalls2since 2021
Last 12 months0reported
Class I00% of total
Ongoing0latest 28 Feb 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 1 50%Class III 1 50%
Why oseltamivir phosphate is recalled
Companies
By year
All oseltamivir phosphate recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Oseltamivir Phosphate for Oral Suspension 6mg/ml (reconstituted) recalledOseltamivir Phosphate | Amneal Pharmaceuticals of New York | Potency & Assay | Nationwide |
| Drug | CLASS III | Oseltamivir Phosphate for Oral Suspension, 6 mg/mL recalledOseltamivir Phosphate | Lupin Pharmaceuticals | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.